Skip to main content
Tech.euFundingExplorerBeta

Samsara Biocapital

Investor profile

Venture capital

Samsara Biocapital has backed 3 European tech companies across 4 funding rounds between 2021 and 2023, joining rounds totalling €281M. Most active in Healthtech. Data as of Nov 2026.

Deals
4
distinct rounds
Companies
3
backed
Active span
2021–2023
3 yrs
Total round €
€281M
sum of rounds joined

Deals by year

distinct rounds / year
Samsara Biocapital — deals by year — interactive chart.
Data table
Samsara Biocapital — deals by year
20211
20222
20231

Top sectors

by deals
Samsara Biocapital — top sectors — interactive chart.
Data table
Samsara Biocapital — top sectors
Healthtech4

Stages

by deals
Samsara Biocapital — stages — interactive chart.
Data table
Samsara Biocapital — stages
Series A2
Other1
Series B1

Countries

by deals
Samsara Biocapital — countries — interactive chart.
Data table
Samsara Biocapital — countries
UK3
Switzerland1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Samsara Biocapital — 4 dealsSamsara BiocapitalJeito Capital — 2 shared deals · click to openJeito CapitalMRL Ventures Fund — 2 shared deals · click to openMRL Ventures FundSV Health Investors — 2 shared deals · click to openSV Health InvestorsAdage Capital Management — 1 shared deals · click to openAdage Capital ManagementBain Capital Life Sciences — 1 shared deals · click to openBain Capital Life SciencesBioMedPartners — 1 shared deals · click to openBioMedPartnersCureDuchenne Ventures — 1 shared deals · click to openCureDuchenne VenturesDeerfield — 1 shared deals · click to openDeerfieldFiscus Financial — 1 shared deals · click to openFiscus FinancialGIMV — 1 shared deals · click to openGIMVGL Capital — 1 shared deals · click to openGL CapitalGray’s Creek Capital Partners — 1 shared deals · click to openGray’s Creek Capital PartnersLaurion Capital Management — 1 shared deals · click to openLaurion Capital ManagementLightspeed Venture Partners — 1 shared deals · click to openLightspeed Venture PartnersMission BioCapital — 1 shared deals · click to openMission BioCapitalOmega Funds — 1 shared deals · click to openOmega FundsOxford Sciences Innovation — 1 shared deals · click to openOxford Sciences InnovationPeak6 Strategic Capital — 1 shared deals · click to openPeak6 Strategic Capital

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
EyeBiotechUK2€118M
PepgenUK1€95M
Immunos TherapeuticsSwitzerland1€68M

Biggest deals

top 10 by amount
CompanyStageAmountDate
PepgenOther€95M2021-08
Immunos TherapeuticsSeries B€68M2022-06
EyeBiotechSeries A€61M2023-11
EyeBiotechSeries A€57M2022-02
← Back to investors